Insights
Insights From Our Experts
Articles
Five Trends That Will Shape the Current and Future Payer Market Landscape
As leading payers build new business models to ultimately advance their approaches to care and drug management, biopharmaceutical companies need to adjust their account engagement and drug access strategies accordingly. Here are a the top five…
Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth
As C-suite leaders in pharma wrestle with the pros and cons of launching alone, licensing or partnering with another company to launch their product, one factor they must consider is the impact their decision will have…
Turning Theory Into Action: How Real-World Evidence Drives Clinical Research and Improves Patient Outcomes
Life sciences companies have made significant investments in real-world data (RWD), but most established providers can deliver only a fraction of what’s needed to be impactful. Breaking down traditional healthcare silos for a more innovative approach…
BLOG: The ABCDs of Medicare Drug Coverage
The Medicare benefit is divided into four parts, each providing a unique drug benefit. Together, the four parts provide medication coverage – from oral medications taken at home to IV treatments given in a physician’s office…
Precision Medicine and Predictive Action Drive Measurable Impact for Patients
The Institute for Precision Medicine defines “Precision Medicine” as the “medical approach that proposes to prevent and treat disease based upon a person’s unique genetic makeup and their lifestyle habits. Precision medicine, the ability to accurately…
Webinar: Improve Hub Performance and Patient Outcomes
The use of health data technologies and analytics in the life sciences industry continues to evolve, but many manufacturers are still crawling around in the dark. With limited in-person patient and provider-rep interactions, hubs that lack…
How to Scale Your Learning & Development Department: Ask The Expert
For years, Learning and Development teams have been asked to “do more with less.” When budgets tightened, teams would get more creative allocating their resources and time. But today – in the midst of changing market…
Webinar: CMS Final Rule on Cost-Sharing Assistance
The CMS final rule on drug reimbursement addresses how co-pay coupons and vouchers are being exempted from deductibles by PBMs. The rule seems to ensure that the full value of manufacturers’ coupon and voucher programs accrue…
Change Is Happening in the EU: What Pharma Companies Need to Know About the European Union’s New Pharmaceutical Strategy
For the first time, the European Union is undergoing a major overhaul of its pharmaceutical industry with the new Pharmaceutical Strategy for Europe, which was launched in late 2020. Through this strategy, the European Union (EU) is making…
News Alert: MCIT Implementation Delayed
On Friday, March 12, the Centers for Medicare and Medicaid Services (CMS) issued an Interim Final Rule with Comment (IFC) delaying the effective date of the Medicare Coverage of Innovative Technologies (MCIT) initiative from March 15…